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teinuria independently of both hypertension and diabetes mel-Influence of smoking and obesity on the development of pro-
litus in men. The risk of developing proteinuria also tendedteinuria.
to be increased with cigarette smoking in men. Smoking andBackground. Proteinuria is a significant risk factor for end-
obesity in women were not significant in this data set.stage renal disease. Previous evidence suggested that smoking
and obesity increase the risk of proteinuria. However, it is
unclear whether these risk factors predict the development of
proteinuria independently of hypertension and diabetes melli- Proteinuria was identified as a significant predictor oftus. The aim of this study was to analyze the effects of obesity
end-stage renal disease (ESRD) in a mass screening ofand smoking on the development of proteinuria in a screened
volunteers [1], and reported as a risk factor for cardiovas-cohort of subjects with normal kidney function.
Methods. A total of 5403 subjects (3403 men and 2000 women) cular or total mortality [2, 3]. Microalbuminuria is a
who participated in the 1997 and 1999 health screening exami- predictor of nephropathy in diabetic patients [4, 5] and
nations in Okinawa Japan, and who were normal renal function is associated with renal functional abnormalities in non-
(serum creatinine 1.2 mg/dL in men, 1.0 mg/dL in women)
diabetic subjects [6]. Smoking was reported as an associ-and negative proteinuria by dipstick examination in 1997 were
ated factor with microalbuminuria, independently ofeligible for study. Logistic analysis was used to examine the
relation between the baseline state of smoking or obesity in blood pressure, in a cross sectional study including hyper-
1997, and the development of proteinuria in 1999, adjusted for tensive and non-hypertensive patients [7], and in type 1
age, sex, and other confounding factors. [8] and type 2 diabetes mellitus [9–11]. Furthermore,
Results. Proteinuria developed in 5.8% of participants (6.7% Orth et al’s retrospective study showed that smokingin men, 4.4% in women; dipstick score, 1 in 277, 2 in 37, and
increased the risk of ESRD in men diagnosed with IgA3 in 4 participants). The incidence of proteinuria was posi-
nephropathy or autosomal dominant polycystic kidneytively associated with the number of cigarettes smoked per day
(P  0.04), and a body mass index (P  0.0001) at baseline. disease [12]. A large number of reports on the effects
Analysis showed that the relative risk (95% confidence inter- of smoking on the kidney are available; however, studies
val) of developing proteinuria was 1.32 (1.00 to 1.74), P 0.04 concerning the impact of smoking on renal function infor cigarette smoking, 1.45 (1.13 to 1.86), P 0.002 for obesity,
subjects without renal disease are scarce [13, 14].1.56 (1.19 to 2.06), P  0.001 for hypertension, and 2.27 (1.55
In hypertensive and non-hypertensive patients diag-to 3.32), P  0.0001 for diabetes mellitus. Stratified with men
and women, the relative risk was 1.28 (0.96 to 1.72), P  0.09 nosed with type 2 diabetes mellitus, obesity was associ-
for smoking, and 1.60 (1.19 to 2.14), P  0.001 for obesity in ated with microalbuminuria [10, 11, 15], and urinary
men; the relative risk was 1.30 (0.44 to 3.80), P  0.62 for albumin excretion has been positively and significantly
smoking, and 1.04 (0.63 to 1.72), P 0.87 for obesity in women.
correlated with body weight [16]. Compared with the con-Conclusions. Hypertension and diabetes mellitus were supe-
trol group, urinary albumin excretion was significantlyrior to smoking and obesity in predicting the development of
proteinuria in all subjects. Stratified with men and women, higher in the obese patients [17]. In large cross-sectional
obesity was a significant risk factor for the development of pro- health screening studies of middle-aged men and women
known to be non-diabetic, non-hypertensive, non-lipid-
emic, and non-proteinuric, obesity correlated with uri-Key words: cigarettes, tobacco, end-stage renal disease, overweight,
nary albumin excretion [18]. Furthermore, a significanthypertension, diabetes mellitus, cardiovascular disease, blood pressure,
renal failure. correlation has been observed between body weight loss
and a decrease in proteinuria [19]. However, a largeReceived for publication June 18, 2001
follow-up study has not been available.and in revised form March 25, 2002
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hort of subjects with normal renal function and without or the current use of antihypertensive medication. Obe-
sity was defined as body mass index (BMI) 25 kg/m2,proteinuria. The established risk of hypertension and
diabetes mellitus for renal failure and ESRD [20, 21] calculated as body weight (kg) divided by the square of
the height (m2) [25]. Diabetes mellitus was diagnosed ifwas adjusted for in the statistical analysis of the data, so
that the true effect of smoking and obesity on proteinuria fasting blood glucose level was 126 mg/dL (7 mmol/L)
[26], HbA1c was 7.0%, or the subject was under dia-could be observed independently of these variables.
betes mellitus therapy. Hypercholesterolemia was de-
fined as total cholesterol 220 mg/dL (5.69 mmol/L)
METHODS
[27]. Hypertriglyceridemia was defined as triglycerides
The characteristics of this ongoing screening program 150 mg/dL (1.7 mmol/L) [28]. Anemia was defined as
in which subjects in the present study participated have blood hemoglobin concentration less than mean  2 SD
been reported previously [22, 23]. The screening is one- of the subjects (14.0 g/dL in men, and 11.0 g/dL in
day clinic program run by the Okinawa General Health women). Hyperuricemia was defined as serum uric acid
Maintenance Association, and involves a thorough phys- 7.0 mg/dL (420 mol/L) [29].
ical examination for about 10,000 adults who presently
participate each year. Among 9914 subjects screened in Statistical methods
1997, 8419 had a normal renal function [serum creatinine The unpaired t test or 	2 test was used to compare
(SCr) 1.2 mg/dL in men, 1.0 mg/dL in women] and values or ratios between groups. Trends of frequency were
negative proteinuria by dipstick examination. Of these tested by multiple regression analysis or analysis of vari-
normal renal function subjects, 5403 subjects partici- ance (ANOVA). Difference of distribution for frequency
pated in the repeat 1999 program, but 3016 subjects between dropped and included subjects also was tested
did not. Finally, a total of 5403 subjects (3403 men, 2000 by the Wilcoxon rank sum test. Relative risk of protein-
women) were included in the analysis for the present uria was estimated with the use of logistic regression
study. This study was conducted in accordance with the models (StatView 5.0; SAS Institute, Cary, NC, USA).
principles set out in the Declaration of Helsinki 1975, These particular variables for the multivariable logistic
as revised in 1993. The study design was approved by regression model were selected because they were thought
the ethical committee of the Association. Only the field to be related to cardiovascular risk, mortality risk, renal
data set that excluded information such as name and ad- risk and renal function. Logistic analysis was used to find
dress was used for this study. After the nature of screen- the predictor of developing proteinuria. Table 2 lists the
ing was explained, all participants signed the question- variables included in the multivariate analysis. We did
naire. not use a stepwise selection method. P 0.05 was consid-
The following parameters were noted in the self- ered significant.
administered, standardized questionnaire: family history
of hypertension, presence of diabetes mellitus, current
RESULTScigarette smoking habit (0, 1 to 10, 11 to 20, and 21
cigarettes per day), level and incidence of alcohol con- Basal characteristics in 1997 of subjects who dropped
out and those who were included in analysis are shownsumption, and the amount of physical exercise under-
taken. To corroborate this information these subjects were in Table 1. Serum creatinine and the prevalence of hy-
pertriglyceridemia, hyperuricemia, and current drinkerinterviewed by a physician. Dipstick urinalysis (Ames
dipstick) was performed on fresh, mid-stream urine col- were significantly higher in subjects who were included
in analysis than in those who dropped out. Age and thelected in the morning. The results of the urine test were
interpreted as (), (/), (1), (2), (3) and (4). prevalence of diabetes mellitus were significantly lower
in subjects who were included in analysis than in thoseHeight, body weight, blood pressure, blood hemoglobin
(Hb), fasting blood glucose, HbA1c, serum creatinine, who dropped out. Because the number of subjects was
relatively large, the prevalence of some risk factors wasuric acid, total cholesterol, and triglycerides were mea-
sured in all subjects. After 15 minutes of sitting, blood statistically different between the two groups (Table 1).
However, no difference was found in the prevalence ofpressure was measured twice by a trained nurse using a
standard sphygmomanometer. The lower value of two obesity and smoking between the two groups. Further-
more, the entire trends of the prevalence of risk fac-blood pressure measurements was used for this study.
Normal renal function was defined as SCr 1.2 mg/dL tors between subjects who dropped out and those who
were included in analysis were comparable (P  0.83 byin men and 1.0 mg/dL in women. Negative proteinuria
was defined as a dipstick proteinuria () and (/), ANOVA). For prevalence of risk factors, there was no
observed difference (P  0.40) between the droppedand a positive proteinuria was defined as (1) or more.
Hypertension was defined as systolic blood pressure and included subjects by Wilcoxon rank sum test.
In 1999, proteinuria was recorded in 318 of the subjects140 mm Hg, diastolic blood pressure90 mm Hg [24],
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Table 1. Baseline characteristics of subjects who were included in analysis and subjects with normal renal function and
negative proteinuria in 1997 who dropped out as well as baseline characteristics of those included in the analysis
divided by whether or not they developed proteinuria in 1999
Subjects (N8419) Proteinuria in 1999 (N5403)
Dropped out Included in analysis No Yes
Characteristics (N3016) (N5403) (N5085) (N318)
Mean age
SD years 49
11 48
9a 48
9 48
9
Sex % male 52 62a 62 72b
Mean serum creatinine
SD mg/dL 0.94
0.15 0.97
0.15a 0.97
0.15 0.98
0.14
Obesity % 33 34 33 47b
Hypertension % 23 21 21 31b
Hypercholesterolemia % 34 33 33 36
Hypertriglyceridemia % 27 31a 31 42b
Diabetes mellitus % 6.6 5.1a 4.7 12b
Hyperuricemia % 16 18a 18 22
Anemia % 6.8 6.3 6.2 8.1
Current drinker % 59 65a 65 72b
Current smoker % 27 28 28 36b
Habitual exerciser % 35 36 37 35
Definitions of the clinical characteristics are described in the text. The trends of prevalence of risk factors between subjects dropped out and included in analysis
were comparable (P  0.83 by ANOVA).
a P  0.05 vs. subjects dropped out
b P  0.05 vs. no proteinuria
(5.8% total; 6.7% in men, 4.4% in women, P  0.001 vs. was positive in all subjects (P  0.0001). The incidence
of proteinuria was significantly associated with BMI formen): 1 (N  277), 2 (N  37), 3 (N  4). Base-
line characteristics of 5403 subjects divided by the pres- men (P  0.0001), but not in women (P  0.4) (Fig. 2).
Table 2 presents the results of multivariate logisticence or absence of proteinuria in 1999 also are shown
in Table 1. Subjects who developed proteinuria were analysis of predictors for developing proteinuria in sub-
jects with normal renal function and negative proteinuriamore likely to be male, obese, and hypertensive. They
were also more likely to have hypertriglyceridemia, dia- (N  5403). The dependent variable was positive pro-
teinuria in 1999. Current smoking, obesity, hypertensionbetes mellitus, drinking and smoking habits. Comparing
the prevalence values in men with those in women among and diabetes mellitus were statistically significant after
adjustment for age, sex, hypercholesterolemia, hypertri-5403 subjects, the prevalence of obesity (men vs. women,
39.2 vs. 25.7%), hypertension (23.7 vs. 20.5%), hypertri- glyceridemia, anemia, hyperuricemia, drinking habits
and exercise habits. Hypertension and diabetes mellitusglyceridemia (40.7 vs. 15.7%), diabetes mellitus (6.5 vs.
2.9%), hyperuricemia (28.5 vs. 2.0%), current drinker were superior to smoking and obesity in predicting the
development of proteinuria.(87.7 vs. 26.8%), current smoker (43.0 vs. 4.5%), and
habitual exerciser (39.6 vs. 31.6%) were higher in men A sex difference may be present for the relationship
between smoking or obesity and the development ofthan in women (P  0.0001, respectively).
We did not analyze the relationship between protein- proteinuria (Figs. 1 and 2). Therefore, we also analyzed
the data separately in men (N  3403, mean age 
 SD,uria and the risk factors in 1999 because complete data
set in 1999 was not available. However, the body mass 47 
 9 years old) and women (N  2000, 50 
 9 years
old; Table 3). Current smoking was significant in theindex (BMI) in 1999 was obtained. According to the
data, 34% of all subjects were obese in 1997; 31% of all unadjusted model and showed a trend in the adjusted
model in men, but was not significant in women. Obesitysubjects maintained obese from 1997 to 1999, and 4%
of all subjects newly developed obesity in 1999. and diabetes mellitus were significant predictors for de-
veloping proteinuria only in men but not in women.The correlation between incidence of newly developed
proteinuria and the baseline number of cigarettes smoked There was a trend for hypertension in men (P  0.05
in the adjusted model). Hypertension was a significantper day was significantly positive in all subjects (P 
0.04), adjusted for age and sex (Fig. 1). Since the number predictor for the development of proteinuria in women
(P  0.002 in adjusted model).of women who smoked in the sample population was
small, no correlation was evident in women. Figure 2 The data were analyzed after excluding the hyperten-
sive and diabetic patients in 1997 from the study group.shows the incidence of proteinuria in 1999 according to
the baseline BMI in 1997 divided by the WHO classifica- In all subjects (2465 men, 45
 9 years old; 1589 women,
48 
 9 years old; mean age 
 SD), the relative risk oftion of obesity [25]. After being adjusted for age and
sex, the correlation of incidence of proteinuria to BMI developing proteinuria was 1.33 (0.96 to 1.85; P  0.08)
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Fig. 1. Incidence of proteinuria according to the number of cigarettes
Fig. 2. Incidence of proteinuria according the baseline body mass indexsmoked per day. Trends were significant for all subjects (; P  0.04)
(BMI). Trends were significant for all subjects (; P 0.0001) when ad-when adjusted for age and sex, but not significant when adjusted for
justed for age and sex, and when adjusted for age in men ( ; P 0.0001),age in men ( ; P  0.07) or in women (; P  0.9).
but not significant when adjusted for age in women (; P  0.4).
Table 2. Results of the logistic analysis of developing proteinuria in 5403 subjects with normal renal function and negative proteinuria
Not adjusted Adjusteda
Predicting factors  RR (95% CI) P  RR (95% CI) P
Current smoking (vs. non-smoker) 0.38 1.47 (1.15–1.86) 0.001 0.28 1.32 (1.00–1.74) 0.04
Obesity (vs. non-obesity) 0.43 1.54 (1.22–1.95) 0.0003 0.37 1.45 (1.13–1.86) 0.002
Hypertension (vs. normotension) 0.41 1.51 (1.17–1.95) 0.001 0.45 1.56 (1.19–2.06) 0.001
Diabetes mellitus (vs. non-diabetes) 0.82 2.28 (1.58–3.31) 0.0001 0.82 2.27 (1.55–3.32) 0.0001
Abbreviations are: RR, relative risk; CI, confidence interval.
a Adjusted for other predicting factors in the Table and other confounding variables such as age, sex, hypercholesterolemia, hypertriglyceridemia, anemia,
hyperuricemia, drinking habits, and exercise habit. The definitions of these factors are described in the text.
for smoking, and 1.51 (1.11 to 2.07; P 0.008) for obesity glucose or HbA1c measurements, respectively. In all sub-
jects (2241 men, 45 
 9 years old; 1492 women, 48 
 9after an adjustment for age, sex, hypercholesterolemia,
hypertriglyceridemia, anemia, hyperuricemia, drinking years old; mean age 
 SD), the relative risk of devel-
oping proteinuria was 1.40 (0.95 to 2.06; P  0.08) forhabits and exercise habits. When men and women were
stratified for smoking, the adjusted relative risk of devel- smoking, and 1.45 (1.02 to 2.06; P  0.03) for obesity
after an adjustment with age, sex, hypercholesterolemia,oping proteinuria was 1.25 (0.87 to 1.81; P  0.22) in
men and 1.50 (0.50 to 4.41; P  0.46) in women. For hypertriglyceridemia, anemia, hyperuricemia, drinking
habits and exercise habits. When men and women wereobesity the relative risk was 1.74 (1.20 to 2.51; P 0.003)
in men and 0.98 (0.51 to 1.88; P  0.95) in women. stratified for smoking, the adjusted relative risk of devel-
oping proteinuria was 1.36 (0.89 to 2.06; P  0.14) inThese data showed obesity was a significant predictor
for developing proteinuria in non-hypertensive and non- men and 1.59 (0.53 to 4.74; P  0.40) in women; and for
obesity the adjusted relative risk was 1.74 (1.15 to 2.64;diabetic men.
We also analyzed the data after excluding the hyper- P  0.008) in men and 0.81 (0.38 to 1.73; P  0.60) in
women. These data suggested that obesity was a signifi-tensive and diabetic patients in 1997 or 1999 from the
study group. However, since data for hypertensive or cant predictor for developing proteinuria in non-hyper-
tensive and non-diabetic men.diabetic therapy in 1999 were not obtained, the diagnosis
of hypertension or diabetes mellitus in 1999 was deter- To assess the probability of developing proteinuria ac-
cording to risk factor-clustering, two sets of logistic mod-mined only by the blood pressure values and fasting blood
Tozawa et al: Smoking, obesity, risk of proteinuria960
Table 4. Odds ratio (95% confidence interval) for developing
proteinuria based on the number of risk factors: smoking,
obesity, hypertension, and diabetes mellitusa
Odds ratio (95% confidence interval)
Number of risk factors Not adjusted Adjustedb
None (N2018) 1.00 1.00
One (N2130) 1.79 (1.33–2.41) 1.67 (1.22–2.29)
Two (N995) 2.39 (1.72–3.33) 2.18 (1.51–3.14)
Three (N214) 4.12 (2.59–6.55) 3.82 (2.31–6.29)
Four (N21) 13.71 (5.36–35.02) 12.21 (4.67–31.89)
a Patients whose smoking habits were not known in 1997 (N 25) were excluded
b Adjusted for age, sex, hypercholesterolemia, hypertriglyceridemia, anemia,
hyperuricemia, drinking habit, and exercise habit. The definitions of these factors
are described in the text.
els were used (Table 4). Each assessed the single and
cumulative number of risk factors from significant pre-
dictors of proteinuria: smoking, obesity, hypertension,
and diabetes mellitus. Adjustments were made for age,
sex, hypercholesterolemia, hypertriglyceridemia, ane-
mia, hyperuricemia, alcohol-drinking status, and physical
exercise. The magnitude of the estimates in the two sets
of models showed that an increasing number of risk
factors indicated a higher risk of proteinuria.
DISCUSSION
Smoking is a significant risk factor of proteinuria in
various clinical settings such as hypertension, non-hyper-
tension [7], type 1 diabetes [8], type 2 diabetes [9–11],
and screened men [3]. Halimi et al’s study of 28,409
volunteers reported in that the unadjusted odds ratio
(95% confidence interval) of a current or former smoker
was 2.15 (1.56 to 3.00) for a dipstick score of 1 or
higher proteinuria [14]. From the Multiple Risk Factor
Intervention Trial (MRFIT) cohort, Grimm et al re-
ported that smoking predicted the incidence of 1 or
higher proteinuria through 72 months in 12,866 men;
the odds ratio was 1.28 (1.14 to 1.43) with multivariate
adjustments [3]. In our present study, current cigarette
smoking predicts the development of proteinuria in all
subjects independent of hypertension and diabetes melli-
tus. After a stratification of men and women, there was
only a trend in men (N  3403) and no significance in
women (N  2000). The relatively small number of sub-
jects may limit the statistical power, however.
A large body of literature has remarked on the po-
tential adverse effects of cigarette smoking on health
[12, 13]. Infusion of nicotine into the renal artery in-
creases glomerular filtration rates (GFR) [30]. In a large
cross-sectional study (N  7476), the percentage of sub-
jects with an elevated GFR was significantly larger in
current smokers (5.4%) than non-smokers (3.0%) [31].
An increase in GFR induced by smoking could generate
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hyperfiltration, a risk factor for progression to chronic
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Table 5. Frequency of proteinuria examined by dipstick test in relatively large studies
References Area surveyed Year of survey N (men/women) Age Frequency of proteinuria
Culleton et al [2] USA (Framingham) 1977 2586 (1045/1541) 68 Men (6.3%), women (3.4%)a
Grimm et al [3] USA (MRFIT) 1973–1980 12,866 (men) 35–57 3.3–6.7%,a 2.4%/yearb
Halimi et al [14] France 1998 28,409 20–69 0.7%a
Von Bonsdorff et al [40] Finland 1976 36,147 (men) 20 0.4%a
Tozawa et al [present study] Japan (Okinawa) 1997 9908 18–89 6.4%a
1997–1999 5403 (3403/2000) 48 Men (3.3%/year), women (2.2%/year)b
Age represents mean or range (years).
a Prevalence
b Incidence
renal disease [32]. Furthermore, secretion of vasopressin abetes or hypertension may be greater than obesity and
smoking. In the present study, the risk of developingis increased during smoking, and vasopressin increases
GFR inappropriately via changing the activity of tubu- proteinuria was also increased by the combination of four
risk factors: smoking, obesity, hypertension, and diabetesloglomerular feedback [33].
Proteinuria is relatively common in obese patients. mellitus. Ribstein, du Cailar and Mimran also showed
that obesity magnified the effects of hypertension on al-Dornfeld reviewed 1000 obese subjects and revealed 410
(41.0%) cases of proteinuria with normal urine sedi- buminuria [35]. Together these results suggest that mul-
tiple risk factors increase the risk of developing pro-ments [34]. Body mass index was strongly correlated with
microalbuminuria in a cross-sectional population-based teinuria.
Frequency of proteinuria examined by the dipstickstudy [18]. Praga et al reported that hypocaloric diets
decreased body weight as well as proteinuria in nine test is different in surveyed areas worldwide (Table 5).
The prevalence of proteinuria in the USA [2, 3] andobese patients [19]. Proteinuria in obesity may be benign;
however, it was reported that out of 1000 obese patients Japan (the present study) were higher than in France
[14] and Finland [40]. However, the frequency of protein-53 (5.3%) had an abnormal urinary sediment [34]. A
larger study to determine the effect of weight reduction uria was comparable between USA and Japan, or France
and Finland. Factors including race, environmental back-on proteinuria should be carried out.
The mechanisms by which obesity induce renal injury grounds, age, and rate of men in the studied cohorts may
contribute to the difference. The prevalence of diabetesare poorly understood. Obesity is associated with renal
hyperfiltration and hyperperfusion [35]. Kidneys from mellitus and hypertension also could account for the dis-
crepancies among these studies; for example, the preva-obese subjects exhibit focal glomerulosclerosis and other
histologic changes similar to those observed in diabetic lence of hypertension was 8.9% in France [14] versus
21% in Japan (present study).nephropathy [36]. A recent experimental study in dogs
showed that a high-fat diet caused obesity, glomerular Potential limitations should be considered in the inter-
pretation of this study. First, the duration of proteinuriahyperfiltration and glomerular structural change associ-
ated with a trend for an elevated glomerular transform- that had persisted in each subject before 1997 was un-
known. This may be important since transient protein-ing growth factor (TGF)-1 expression [37].
In the present study, the incidence of developing pro- uria with a resolution on subsequent examination was
reported to be 4% in men and 7% in women [41]. Second,teinuria was greater in men than in women; this is proba-
bly due to the prevalence of cigarette smoking, obesity, it might be uncertain that a single dipstick urine test
could reflect organ damage and thus be a reliable prog-hypertension and diabetes mellitus in the male popula-
tion as a whole. This gender difference is further high- nostic test for the progression of renal disease. How-
ever, Davidson and Smiley reported that a 1 or higherlighted as men are more likely to progress to renal disease
[38], and it has been shown worldwide that a higher dipstick-positive proteinuria was highly predictive of
abnormal urinary albumin/creatinine ratios [42]. Withnumber of men are accepted for dialysis than women.
Animal studies have shown that sex-related hormones microalbuminuria, a chance dipstick measurement of
proteinuria predicted ESRD; a dose-dependent relation-were involved when explaining gender differences in the
incidence of proteinuria and glomerulosclerosis [39]. ship was observed between the degree of dipstick pro-
teinuria and a risk of ESRD [1]. Furthermore, anotherIn all subjects diabetes mellitus is followed by hyper-
tension, obesity and smoking as the most important risk study found that casual dipstick proteinuria was a sig-
nificant risk factor for all-cause mortality [2].factors for developing proteinuria (Table 4). Hyperten-
sion in women or diabetes mellitus men was the strongest In summary, hypertension in women, and diabetes
mellitus in men were significant risk factors for devel-predictor of the forthcoming proteinuria in each group
(Table 3). It should be emphasized that influence of di- oping proteinuria. Hypertension in men showed a trend
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